118 related articles for article (PubMed ID: 37024111)
21. [Value of interleukin-6 and CD4
Shi X; Qin L; Yang L; Bai W; Jing L; Mei K
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Oct; 32(10):1165-1170. PubMed ID: 33198856
[TBL] [Abstract][Full Text] [Related]
22. Circulating cell-free DNA, peripheral lymphocyte subsets alterations and neutrophil lymphocyte ratio in assessment of COVID-19 severity.
Hammad R; Eldosoky MAER; Fouad SH; Elgendy A; Tawfeik AM; Alboraie M; Abdelmaksoud MF
Innate Immun; 2021 Apr; 27(3):240-250. PubMed ID: 33646058
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of Inflammatory Biomarkers in Patients with Severe COVID-19: A Single-Center Retrospective Study.
Açıksarı G; Koçak M; Çağ Y; Altunal LN; Atıcı A; Çelik FB; Bölen F; Açıksarı K; Çalışkan M
Biomark Insights; 2021; 16():11772719211027022. PubMed ID: 34248354
[TBL] [Abstract][Full Text] [Related]
24. [An increased neutrophil/lymphocyte ratio is an early warning signal of severe COVID-19].
Xia X; Wen M; Zhan S; He J; Chen W
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Mar; 40(3):333-336. PubMed ID: 32376581
[TBL] [Abstract][Full Text] [Related]
25. Usefulness of the neutrophil-to-lymphocyte ratio in predicting the severity of COVID-19 patients: a retrospective cohort study.
Yılmaz E; Ak R; Doğanay F
Sao Paulo Med J; 2022; 140(1):81-86. PubMed ID: 34346985
[TBL] [Abstract][Full Text] [Related]
26. Prognostic accuracy of inflammatory markers in predicting risk of ICU admission for COVID-19: application of time-dependent receiver operating characteristic curves.
Geraili Z; Hajian-Tilaki K; Bayani M; Hosseini SR; Khafri S; Ebrahimpour S; Javanian M; Babazadeh A; Shokri M
J Int Med Res; 2022 Jun; 50(6):3000605221102217. PubMed ID: 35701893
[TBL] [Abstract][Full Text] [Related]
27. The use of neutrophil-to-lymphocyte ratio (NLR) as a marker for COVID-19 infection in Saudi Arabia: A case-control retrospective multicenter study.
Sayed AA; Allam AA; Sayed AI; Alraey MA; Joseph MV
Saudi Med J; 2021 Apr; 42(4):370-376. PubMed ID: 33795491
[TBL] [Abstract][Full Text] [Related]
28. Immune dysfunction following COVID-19, especially in severe patients.
Song CY; Xu J; He JQ; Lu YQ
Sci Rep; 2020 Sep; 10(1):15838. PubMed ID: 32985562
[TBL] [Abstract][Full Text] [Related]
29. [Expressions of MPV, P-LCR and NLR in patients with novel coronavirus disease 2019].
Xu HM; Liu J; Gu CG; Zhang JD; Liu MR; Yuan FL; Liu SY
Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Jul; 55(7):890-895. PubMed ID: 34304428
[TBL] [Abstract][Full Text] [Related]
30. The neutrophil to lymphocyte ratio is an independent predictor for severe COVID-19 : Evidence from a multicenter case-control study and meta-analyses.
Cheng J; Ma A; Yang J; Dong M; Liao X; Kang Y
Wien Klin Wochenschr; 2021 Sep; 133(17-18):882-891. PubMed ID: 34342712
[TBL] [Abstract][Full Text] [Related]
31. Sex-Dependent Performance of the Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte and Mean Platelet Volume-to-Platelet Ratios in Discriminating COVID-19 Severity.
Fors M; Ballaz S; Ramírez H; Mora FX; Pulgar-Sánchez M; Chamorro K; Fernández-Moreira E
Front Cardiovasc Med; 2022; 9():822556. PubMed ID: 35463770
[TBL] [Abstract][Full Text] [Related]
32. Monitoring peripheral neutrophil and T-lymphocyte subsets could assist in differentiating the severity and disease progression of coronavirus disease 2019.
Meng L; Xu J; Zhang J; Zhang K; Shang P; Li Q; Li Y; Wang L; Cai B
Aging (Albany NY); 2021 Mar; 13(6):7723-7732. PubMed ID: 33741750
[TBL] [Abstract][Full Text] [Related]
33. Neutrophil-to-Lymphocyte Ratio, derived Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio as risk factors in critically ill COVID-19 patients, a single centered study.
Noor A; Akhtar F; Tashfeen S; Anwar N; Saleem B; Khan SA; Akram Z; Shahid S
J Ayub Med Coll Abbottabad; 2020; 32(Suppl 1)(4):S595-S601. PubMed ID: 33754514
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the clinical characteristics and early warning model construction of severe/critical coronavirus disease 2019 patients].
Xu J; Zhao F; Han M; Ma L; Zhang T
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Apr; 32(4):401-406. PubMed ID: 32527341
[TBL] [Abstract][Full Text] [Related]
35. [Biochemical analysis between common type and critical type of COVID-19 and clinical value of neutrophil/lymphocyte ratio].
Li H; Zhao M; Xu Y
Nan Fang Yi Ke Da Xue Xue Bao; 2020 Jul; 40(7):965-971. PubMed ID: 32895161
[TBL] [Abstract][Full Text] [Related]
36. Neutrophil to Lymphocyte Ratio (NLR) and Derived NLR Combination: A Cost-effective Predictor of Moderate to Severe COVID-19 Progression.
Ardestani SK; Salehi MR; Attaran B; Hashemi SM; Sadeghi S; Ghaffarpour S; Tuserkani F; Ghazanfari T
Iran J Allergy Asthma Immunol; 2022 Jun; 21(3):241-253. PubMed ID: 35822675
[TBL] [Abstract][Full Text] [Related]
37. The relationship between platelet-to-lymphocyte ratio and pulmonary embolism severity in acute pulmonary embolism.
Telo S; Kuluöztürk M; Deveci F; Kirkil G
Int Angiol; 2019 Feb; 38(1):4-9. PubMed ID: 30618227
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.
Liu L; Zheng Y; Cai L; Wu W; Tang S; Ding Y; Liu W; Kou G; Xiong Z; Wang S; Zheng S
Int J Lab Hematol; 2021 Apr; 43(2):329-335. PubMed ID: 33099889
[TBL] [Abstract][Full Text] [Related]
39. Clinical and hematological characteristics of 88 patients with COVID-19.
Zhang H; Cao X; Kong M; Mao X; Huang L; He P; Pan S; Li J; Lu Z
Int J Lab Hematol; 2020 Dec; 42(6):780-787. PubMed ID: 32779860
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of neutrophils to lymphocytes and platelets ratio for 28-day mortality in patients with acute respiratory distress syndrome: a retrospective study.
Nie S; Wang H; Liu Q; Tang Z; Tao W; Wang N
BMC Pulm Med; 2022 Aug; 22(1):314. PubMed ID: 35971101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
